![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1441420
¼¼°èÀÇ ¾ç¼öõÀÚħ ½ÃÀå ±Ô¸ð Á¶»ç ¹× ¿¹Ãø : À¯Çüº°, ¼ö±âº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº° ºÐ¼®(2023-2030³â)Global Amniocentesis Needle Market Size study & Forecast, by Type by Procedure, by End-Use and Regional Analysis, 2023-2030 |
¼¼°èÀÇ ¾ç¼öõÀÚħ ½ÃÀåÀº 2022³â¿¡ ¾à 1¾ï 7,591¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, ¿¹Ãø ±â°£ 2023³âºÎÅÍ 2030³â±îÁö 6.85% ÀÌ»óÀÇ °ß½ÇÇÑ ¼ºÀå·ü·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.
¾ç¼öõÀÚħÀº ¾ç¼öõÀÚ¶ó´Â Áø´Ü ÀýÂ÷¿¡ »ç¿ëµÇ´Â Ư¼ö ÀÇ·á±â±âÀÔ´Ï´Ù. ¾ç¼öõÀÚ´Â Áø´Ü ¸ñÀûÀ¸·Î ÀӽŠÁß¿¡ ÀÚÁÖ ¼öÇàµÇ´Â ÀÇ·á ÀýÂ÷ÀÌ¸ç ¾ç¼öõÀÚħÀº ÀÌ °úÁ¤¿¡¼ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ¾ç¼öõÀÚ´Â ¾ç¼ö°Ë»ç¶ó°íµµ ºÒ¸®¸ç ¿°»öü ÀÌ»óÀ̳ª °¨¿°ÁõÀ» È®ÀÎÇϰí žÆÀÇ ¼ºº°À» °áÁ¤Çϴµ¥ ÀÌ¿ëµÇ´Â Ãâ»ýÀü Áø´Ü¹ýÀÔ´Ï´Ù. ÀÌ °Ë»ç´Â ¾à 30 ÀÔ¹æ ¼¾Æ¼¹ÌÅÍÀÇ ¾ç¼ö¸¦ Àڱÿ¡¼ Á¶½É½º·´°Ô äÃëÇÏ¿© ¹ß´ÞÁßÀÎ ¾Æ±âÀÇ ÀáÀçÀû À¯Àü Áúȯ¿¡ ´ëÇÑ ±ÍÁßÇÑ ¹ß°ßÀ» Á¦°øÇÕ´Ï´Ù. ¾ç¼öõÀÚħÀº ³¡ÀÌ ³ª¼± ±¸Á¶·Î µÇ¾î ÀÖ¾î ÃÊÀ½ÆÄ °Ë»ç¿¡¼ÀÇ ½ÃÀμºÀ» ³ô¿© Á¤È®Çϰí Åõ¸í¼ºÀÌ ³ôÀº óġ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¾ç¼öõÀÚħ ½ÃÀåÀº ÀÓ»êºÎÀÇ ¸¸¼ºÁúȯ À¯º´·ü »ó½Â, À¯Àü¼º Áúȯ ¹ß»ý·ü »ó½Â, ÀÓ»êºÎ ¿¬·É »ó½Â µîÀÇ ¿äÀο¡ µû¶ó È®´ëµÇ°í ÀÖ½À´Ï´Ù.
½Å»ý¾ÆÀÇ À¯Àü¼º ÁúȯÀÇ ±ÞÁõÀº Ãâ»ý Àü °Ë»ç¿¡ ´ëÇÑ ÀǽÄÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¾ç¼öõÀÚ Ä¡·á ¼ö¿ä Áõ°¡¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î MJH Life SciencesÀÇ 2022³â º¸°í¼´Â À¯Àü¼º ÁúȯÀÇ ¼¼°è À¯º´·ü »ó½ÂÀ» °Á¶Çϸç, Àü ¼¼°èÀûÀ¸·Î ¿¬°£ ¾à 30¸¸ ¸íÀÇ À¯¾Æ°¡ °â»ó ÀûÇ÷±¸ÁõÀ¸·Î ž´Ù´Â °ÍÀ» ºÐ¸íÈ÷ Çß½À´Ï´Ù. ÀÌ Áúº´Àº ¼¼°è Àα¸ÀÇ 5% °¡±îÀÌ¿¡ °É·Á ÀÖÀ¸¸ç ¹Ì±¹¿¡¼ °¡Àå ÈçÇÑ À¯Àü¼º ÁúȯÀÔ´Ï´Ù. ÀÌ·¯ÇÑ Åë°è´Â žÆÀÇ À¯ÀüÀÚ ÀÌ»óÀ» Á¶±â¿¡ ¹ß°ß ¹× Áø´ÜÇÏ´Â °ÍÀÇ Á߿伺À» °Á¶Çϰí ÀÖ½À´Ï´Ù. ±× °á°ú ¾ç¼öõÀÚħ ½ÃÀåÀº ¿°»öü ÀÌ»óÀ̳ª À¯ÀüÀû ÀÌ»óÀÇ °ËÃâÀ» ¿ëÀÌÇÏ°Ô ÇØ, Ãâ»ý Àü Äɾ ÀÖ¾î¼ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÏ´Â °ÍÀ¸·ÎºÎÅÍ, È®´ë°¡ º¸¿©Áö°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ Ãâ»ý Àü ÄÉ¾î ¹× À¯ÀüÀÚ ½ºÅ©¸®´× ÇÁ·Î±×·¥À» ÃßÁøÇÏ´Â Á¤ºÎÀÇ ÀÌ´Ï¼ÅÆ¼ºê, ¹Ù´ÃÀÇ µðÀÚÀΰú Àç·áÀÇ Áøº¸, ¼¼°èÀÇ ÀÇ·á ÁöÃâ Áõ°¡°¡ ½ÃÀå ¼ºÀåÀÇ »õ·Î¿î ±âȸ¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ºñħ½ÀÀûÀÎ ´ëü ÀÇÇÐÀÌ ÀÌ¿ë °¡´ÉÇØÁø ºÎºÐÀÌ, 2023³âºÎÅÍ 2030³â±îÁö ¿¹Ãø ±â°£ µ¿¾È ½ÃÀåÀÇ ¼ºÀåÀ» ¹æÇØÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.
¼¼°èÀÇ ¾ç¼öõÀÚħ ½ÃÀå Á¶»ç¿¡¼ °í·ÁÇÑ ÁÖ¿ä Áö¿ªÀº ¾Æ½Ã¾ÆÅÂÆò¾ç, ºÏ¹Ì, À¯·´, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÔ´Ï´Ù. ºÏ¹Ì´Â °ß°íÇÑ °Ç° °ü¸® ÀÎÇÁ¶ó, Á¤±³ÇÑ Ãâ»ý Àü ÄÉ¾î ½Ã¼³, ÀÓ»êºÎÀÇ Ãâ»ý Àü °Ë»çÀÇ Á߿伺¿¡ ´ëÇÑ ÀǽÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó 2022³â ÃÖ´ë ½ÃÀå Á¡À¯À²·Î ½ÃÀåÀ» µ¶Á¡Çß½À´Ï´Ù. ºÏ¹Ì°¡ ÀÌ ºÐ¾ß¿¡¼ µ¹ÃâÇÑ ÁöÀ§¸¦ Â÷ÁöÇϰí ÀÖ´Â °ÍÀº ÀÇ·á½Ã¼³³»¿¡¼ ÃÖ÷´ÜÀÇ Áø´Ü ±â¼úÀ̳ª Çõ½ÅÀûÀÎ À¯ÀüÀÚ °Ë»ç¹ýÀÌ ³Î¸® ÀÌ¿ë °¡´ÉÇÏ´Ù´Â °ÍÀÌ Å©°Ô ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ´Ù°í »ý°¢µË´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº ¿¹Ãø ±â°£ µ¿¾È °¡Àå ºü¸¥ ¼Óµµ·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ Áøº¸ÀÇ ±â¼¼´Â Ãâ»ý Àü Äɾî¿Í À¯ÀüÀÚ ½ºÅ©¸®´×ÀÇ Á߿伺¿¡ ´ëÇÑ ÀÇ½Ä Áõ°¡¿¡ ÈûÀÔ°í ÀÖ½À´Ï´Ù. Áß±¹À̳ª Àεµ µî Àα¸°¡ ¸¹Àº ³ª¶ó¿¡¼´Â °íµµÀÇ Ãâ»ýÀü Áø´Ü ¼ö¿ä°¡ ÇöÀúÇÏ°Ô ±ÞÁõÇϰí ÀÖ½À´Ï´Ù. ÀǽÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ¾Æ½Ã¾Æ ±¹°¡¿¡¼´Â Á¾ÇÕÀûÀÎ Ãâ»ý Àü Äɾ ¿ä±¸ÇÏ´Â ÀÓ»êºÎÀÇ ¼ö°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÌ Áö¿ªÀÇ Áö¼ÓÀûÀÎ ±â¼ú Áøº¸´Â ¿ø°Ý ÀÇ·á ¹× µðÁöÅÐ ÀÇ·á ¼Ö·ç¼ÇÀÇ ÃâÇö°ú ÇÔ²² Ãâ»ý Àü °Ë»ç ¼ºñ½º¿¡ ´ëÇÑ ¾×¼¼½º¸¦ È®ÀåÇϰí ÀÖ½À´Ï´Ù.
º» ¿¬±¸ÀÇ ¸ñÀûÀº ÃÖ±Ù ¸î ³âµ¿¾È ´Ù¾çÇÑ ºÎ¹® ¹× ±¹°¡ ½ÃÀå ±Ô¸ð¸¦ ¹àÈ÷°í ¾ÕÀ¸·Î ¼ö³â°£ ½ÃÀå ±Ô¸ð¸¦ ¿¹ÃøÇÏ´Â °ÍÀÔ´Ï´Ù. ÀÌ º¸°í¼´Â Á¶»ç ´ë»ó ±¹°¡¿¡¼ »ê¾÷ÀÇ ÁúÀû ¹× ¾çÀû Ãø¸éÀ» ¸ðµÎ Æ÷ÇÔÇϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù.
¶ÇÇÑ ½ÃÀåÀÇ ¹Ì·¡ ¼ºÀåÀ» ±ÔÁ¤ÇÏ´Â ÃËÁø¿äÀΰú °úÁ¦ µî Áß¿äÇÑ Ãø¸é¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ Á¤º¸µµ Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ ÁÖ¿ä ±â¾÷ÀÇ °æÀï ±¸µµ ¹× Á¦Ç° Á¦°ø¿¡ ´ëÇÑ »ó¼¼ÇÑ ºÐ¼®°ú ÇÔ²² ÀÌÇØ°ü°èÀÚ°¡ ÅõÀÚÇÒ ¼ö ÀÖ´Â ¸¶ÀÌÅ©·Î ½ÃÀåÀÇ ÀáÀçÀûÀÎ ±âȸµµ Æ÷ÇÔÇϰí ÀÖ½À´Ï´Ù.
Global Amniocentesis Needle Market is valued approximately at USD 175.91 Million in 2022 and is anticipated to grow with a healthy growth rate of more than 6.85% over the forecast period 2023-2030. An amniocentesis needle is a specialized medical instrument used in a diagnostic procedure called amniocentesis. Amniocentesis is a medical procedure often conducted during pregnancy for diagnostic purposes and the amniocentesis needle plays a crucial role in this process. Amniocentesis, also referred to as the amniotic fluid test, is a prenatal diagnostic procedure utilized to identify chromosomal abnormalities, infections, and even determine the sex of the fetus. During this test, approximately 30 cubic centimeters of amniotic fluid is carefully collected from the womb, providing valuable insights into potential genetic disorders in the developing baby. The amniocentesis needles are designed with an end featuring a spiral structure, enhancing visibility in ultrasound examinations for precise and transparent procedures. The Amniocentesis Needle market is expanding because of factors such as the rising prevalence of chronic diseases among expectant mothers, the rising incidence of genetic disorders, and increasing maternal age.
The surge in genetic disorders among newborns, coupled with growing awareness of prenatal testing, has fueled an escalating demand for amniocentesis procedures. For instance, a 2022 report by MJH Life Sciences highlighted a global rise in the prevalence of genetic diseases, revealing that globally approximately 300,000 infants are born with sickle cell disease annually. This condition affects nearly 5% of the global population and stands as the most common genetic disorder in the U.S. Such concerning statistics underscore the paramount importance of early detection and diagnosis of genetic abnormalities in fetuses. Consequently, the market for amniocentesis needles is witnessing expansion, given its pivotal role in prenatal care, facilitating the detection of chromosomal and genetic disorders. In addition, Government initiatives promoting prenatal care and genetic screening programs and advancements in Needle Design and Materials, rising healthcare spending globally is creating new opportunities to market growth. However, the availability of non-invasive alternatives stifles market growth throughout the forecast period of 2023-2030.
The key regions considered for the Global Amniocentesis Needle Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 with largest market share owing to robust healthcare infrastructure, sophisticated prenatal care facilities, and a heightened awareness regarding the significance of prenatal testing among expectant parents. The prominent position of North America in the field can be attributed significantly to the widespread availability of cutting-edge diagnostic technologies and innovative genetic testing methods within healthcare facilities. Asia Pacific is expected to grow at a fastest rate during the forecast period. The momentum in this advancement is propelled by a rising awareness of the significance of prenatal care and genetic screening. In countries such as China and India, which boast substantial populations, there is a noticeable surge in the demand for advanced prenatal diagnostics. The increased awareness has resulted in a growing number of pregnant women in Asian countries seeking comprehensive prenatal care. Additionally, continual technological progress in the region, coupled with the emergence of telemedicine and digital healthcare solutions, is broadening the accessibility of prenatal testing services.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below: